HEALTH ITALIA SPA (HI.MI) Stock Fundamental Analysis
BIT:HI - Euronext Milan - IT0005585861 - Common Stock - Currency: EUR
We assign a fundamental rating of 5 out of 10 to HI. HI was compared to 24 industry peers in the Health Care Providers & Services industry. HI scores excellent on profitability, but there are some minor concerns on its financial health. HI has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year HI was profitable.
In the past year HI had a positive cash flow from operations.
Each year in the past 5 years HI has been profitable.
In the past 5 years HI always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 4.16%, HI is doing good in the industry, outperforming 70.83% of the companies in the same industry.
HI has a Return On Equity of 6.91%. This is comparable to the rest of the industry: HI outperforms 50.00% of its industry peers.
HI has a Return On Invested Capital (5.21%) which is comparable to the rest of the industry.
HI had an Average Return On Invested Capital over the past 3 years of 7.13%. This is in line with the industry average of 6.26%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.16% | ||
| ROE | 6.91% | ||
| ROIC | 5.21% |
ROA(3y)3.96%
ROA(5y)3.25%
ROE(3y)7.81%
ROE(5y)6.83%
ROIC(3y)7.13%
ROIC(5y)6%
1.3 Margins
Looking at the Profit Margin, with a value of 7.52%, HI belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
In the last couple of years the Profit Margin of HI has grown nicely.
The Operating Margin of HI (12.85%) is better than 95.83% of its industry peers.
In the last couple of years the Operating Margin of HI has grown nicely.
Looking at the Gross Margin, with a value of 33.27%, HI is in line with its industry, outperforming 54.17% of the companies in the same industry.
HI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.85% | ||
| PM (TTM) | 7.52% | ||
| GM | 33.27% |
OM growth 3Y8%
OM growth 5YN/A
PM growth 3Y33.22%
PM growth 5Y9.47%
GM growth 3Y-1.7%
GM growth 5Y-0.8%
2. Health
2.1 Basic Checks
HI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, HI has more shares outstanding
HI has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, HI has an improved debt to assets ratio.
2.2 Solvency
HI has an Altman-Z score of 2.32. This is not the best score and indicates that HI is in the grey zone with still only limited risk for bankruptcy at the moment.
HI's Altman-Z score of 2.32 is fine compared to the rest of the industry. HI outperforms 75.00% of its industry peers.
The Debt to FCF ratio of HI is 15.21, which is on the high side as it means it would take HI, 15.21 years of fcf income to pay off all of its debts.
HI has a Debt to FCF ratio of 15.21. This is in the lower half of the industry: HI underperforms 70.83% of its industry peers.
HI has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.22, HI belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.22 | ||
| Debt/FCF | 15.21 | ||
| Altman-Z | 2.32 |
ROIC/WACC0.76
WACC6.88%
2.3 Liquidity
HI has a Current Ratio of 3.18. This indicates that HI is financially healthy and has no problem in meeting its short term obligations.
HI's Current ratio of 3.18 is amongst the best of the industry. HI outperforms 95.83% of its industry peers.
A Quick Ratio of 3.18 indicates that HI has no problem at all paying its short term obligations.
HI's Quick ratio of 3.18 is amongst the best of the industry. HI outperforms 95.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.18 | ||
| Quick Ratio | 3.18 |
3. Growth
3.1 Past
HI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.15%, which is quite impressive.
HI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 181.50% yearly.
The Revenue has decreased by -0.86% in the past year.
HI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.37% yearly.
EPS 1Y (TTM)61.15%
EPS 3Y27.76%
EPS 5Y181.5%
EPS Q2Q%504.86%
Revenue 1Y (TTM)-0.86%
Revenue growth 3Y-3.68%
Revenue growth 5Y2.37%
Sales Q2Q%-10.1%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 8.84, the valuation of HI can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of HI indicates a rather cheap valuation: HI is cheaper than 91.67% of the companies listed in the same industry.
HI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.68.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.84 | ||
| Fwd PE | N/A |
4.2 Price Multiples
91.67% of the companies in the same industry are more expensive than HI, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, HI is valued a bit more expensive than 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 39.17 | ||
| EV/EBITDA | 4.59 |
4.3 Compensation for Growth
HI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.05
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for HI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:HI (5/12/2025, 7:00:00 PM)
124
+7 (+5.98%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.56M
Analysts84.44
Price Target438.6 (253.71%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.84 | ||
| Fwd PE | N/A | ||
| P/S | 0.67 | ||
| P/FCF | 39.17 | ||
| P/OCF | 7.7 | ||
| P/B | 0.61 | ||
| P/tB | 0.67 | ||
| EV/EBITDA | 4.59 |
EPS(TTM)14.02
EY11.31%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)3.17
FCFY2.55%
OCF(TTM)16.11
OCFY13%
SpS186.12
BVpS202.44
TBVpS184.42
PEG (NY)N/A
PEG (5Y)0.05
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.16% | ||
| ROE | 6.91% | ||
| ROCE | 9.35% | ||
| ROIC | 5.21% | ||
| ROICexc | 5.54% | ||
| ROICexgc | 5.97% | ||
| OM | 12.85% | ||
| PM (TTM) | 7.52% | ||
| GM | 33.27% | ||
| FCFM | 1.7% |
ROA(3y)3.96%
ROA(5y)3.25%
ROE(3y)7.81%
ROE(5y)6.83%
ROIC(3y)7.13%
ROIC(5y)6%
ROICexc(3y)7.88%
ROICexc(5y)6.76%
ROICexgc(3y)8.74%
ROICexgc(5y)7.6%
ROCE(3y)12.74%
ROCE(5y)10.6%
ROICexcg growth 3Y-3.65%
ROICexcg growth 5YN/A
ROICexc growth 3Y-1.37%
ROICexc growth 5YN/A
OM growth 3Y8%
OM growth 5YN/A
PM growth 3Y33.22%
PM growth 5Y9.47%
GM growth 3Y-1.7%
GM growth 5Y-0.8%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.22 | ||
| Debt/FCF | 15.21 | ||
| Debt/EBITDA | 1.49 | ||
| Cap/Depr | 221.98% | ||
| Cap/Sales | 6.96% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 54.18% | ||
| Profit Quality | 22.63% | ||
| Current Ratio | 3.18 | ||
| Quick Ratio | 3.18 | ||
| Altman-Z | 2.32 |
F-Score7
WACC6.88%
ROIC/WACC0.76
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.15%
EPS 3Y27.76%
EPS 5Y181.5%
EPS Q2Q%504.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.86%
Revenue growth 3Y-3.68%
Revenue growth 5Y2.37%
Sales Q2Q%-10.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.66%
EBIT growth 3Y4.03%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-71.81%
FCF growth 3YN/A
FCF growth 5Y-21.09%
OCF growth 1Y43.49%
OCF growth 3Y55.79%
OCF growth 5Y-20.58%